YMRC
ACLS icon

Yorktown Management & Research Company’s Axcelis ACLS Stock Holding History

Yorktown Management & Research Company’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,700
Closed -$283K – 205
2024
Q3 		$283K Buy
2,700
+600
+29% +$70.2K 0.29% 177
2024
Q2 		$299K Buy
+2,100
New +$242K 0.32% 156
2024
Q1 		– Sell
-2,000
Closed -$259K – 219
2023
Q4 		$259K Buy
+2,000
New +$276K 0.27% 192

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Reinhart Partners
Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Yorktown Management & Research Company's ACLS Position: Q4 2024 in Review

Yorktown Management & Research Company sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 2,700 shares — an estimated $283K sold.

Yorktown Management & Research Company first reported a position in ACLS in Q4 2023 and held it in 3 quarters. The position peaked at $299K in Q2 2024. 325 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Yorktown Management & Research Company reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Yorktown Management & Research Company sold 2,700 Axcelis shares in Q4 2024, an estimated $283K.
  • Yorktown Management & Research Company first reported a position in Axcelis in Q4 2023 and held it in 3 quarters.
  • Yorktown Management & Research Company's Axcelis position peaked at $299K in Q2 2024.
  • 325 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Yorktown Management & Research Company's 13F filing for Q4 2024, filed 27 Jan 2025.